Anaesthesia product has potential in developing world:
This article was originally published in Clinica
An anaesthesia system developed by a UK researcher that is claimed could revolutionise surgery in the developing world has been granted a UK NESTA funding award. Dr Paul Fenton, who has devised a low-cost system combining existing and new technology, has been awarded £33,000 ($47,000) to develop the device for use in remote locations where power supplies may be erratic. The device comprises an oxygen concentrator (not the conventional pipeline or cylinder gas supply), a "Fentolater" valve and modified mechanical ventolater. The NESTA (UK National Endowment for Science Technology and the Arts) award enables Dr Fenton to develop a prototype of the device over the next year.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.